Oncology

Exploring opportunities in areas where Novartis has active efforts, such as breast and lung cancers, melanoma, renal cell carcinoma, and malignant hematology; and we seek to expand into other high-unmet need areas such as hepatocellular, pancreatic, colorectal, and prostate cancers and others. Our partnering teams are organized by stage of development (clinical stage or early), tumour type, or biology of the intervention.

Mark Temples portrait

Mark Temples

Breast and Gynaecological (Ovarian, Endometrial).

Contact

 

Ario Arabi Portrait

 

Ario Arabi

Lung and Melanoma.

Contact

Jesus Baena Portrait

Jesus Baena

Solid Tumours GI/GU.

Contact

 


Hematology

Seeking partners to significantly improve standard of care and cure patients in selected high unmet need in benign hematology diseases. The vision is to transform a number of disease specific classes not limited to hemophilia, complement disorders, anemia, sickle cell disease and thalassemia.

Laura Ripin portrait

Laura Ripin

Leukaemias and Myeloid Dysplastic Syndromes.

Contact

 

Markus Werner portrait

Markus Werner

Lymphomas and Multiple myelomas, CAR-T programs.

Contact

Reza Mazhari portrait

Reza Mazhari

Small molecules for Oncology and all pre PoC deals.

Contact

 

Bose Avirup portrait

Avirup Bose

Non Malignant Hemotology (Sickle Cell Disease).

Contact